Logo
x

Search

Subscribe Now

QIAGEN

QIAGEN’s QIAstat-Dx Respiratory Syndromic Testing Panel Gains the US FDA’s Clearance to Diagnose Upper Respiratory Infections

QIAGEN’s QIAstat-Dx Respiratory Syndromic Testing Panel Gains the US FDA’s Clearance to Diagnose Upper Respiratory Infections

  • May 13, 2024
Michael Scheffler, Vice President, Head of Life Science PCR at QIAGEN Shares Insights on the Addition of New Biopharma Products to its Digital PCR Portfolio

Michael Scheffler, Vice President, Head of Life Science PCR at QIAGEN Shares Insights on the Addition of New Biopharma Products to...

  • October 12, 2022
Qiagen Collaborates with Denovo Biopharma to Develop CDx Test for the Treatment of Diffuse Large B-Cell Lymphoma

Qiagen Collaborates with Denovo Biopharma to Develop CDx Test for the Treatment of Diffuse Large B-Cell Lymphoma

  • December 9, 2021
Qiagen and DiaSorin’s QuantiFERON-TB Gold Plus Assay Receives the US FDA’s Approval for the Treatment of Latent Tuberculosis Infection

Qiagen and DiaSorin’s QuantiFERON-TB Gold Plus Assay Receives the US FDA’s Approval for the Treatment of Latent Tuberculosis Infec...

  • November 29, 2021
PharmaShots Weekly Snapshots (May 24 - 28, 2021)

PharmaShots Weekly Snapshots (May 24 - 28, 2021)

  • May 28, 2021
PharmaShots Weekly Snapshots (Mar 29 - Apr 02, 2021)

PharmaShots Weekly Snapshots (Mar 29 - Apr 02, 2021)

  • April 2, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.